Menu Menu Menu Menu
To Top

Search By Topic

Clinical Trial

64 Articles available
Clinical Trials

Novel Pneumonia-Fighter Enters Pivotal Trial

PAO-M08-17-NI-011
Innovation

Regenerating Knee Cartilage with Stem Cells

PAO-M07-17-NI-020
Drug Development

New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab

PAO-M06-17-NI-020
CRO

CRO’s Move to Fill the Gap

PAO-M06-17-NI-006
Continuous Manufacturing

Cardio Candidate to be Manufactured Continuously

PAO-M06-17-NI-003
Clinical Trials

Clinical Trials Find a Device for Growth

PAP-Q2-17-FA-002
Clinical Trials

HIV Vaccine Demonstrates “Remarkable” Rates

PAO-M05-17-NI-039
Clinical Trials

Priority Review Given to Kite’s Axicabtagene Ciloleucel

PAO-M05-17-NI-034
Clinical Trials

CFDA Calls for Clinical Trial Reform

PAO-M05-17-NI-025
Clinical Trials

New Licensing Agreement Could Lead to Improved Brain Cancer Treatment

PAO-M05-17-NI-017
Clinical Trials

Harmonized Protocol Templates Available for Clinical Trial Sponsors

PAO-M05-17-NI-013
Clinical Trial

Expanding Into Clinical Trials

Jeff Schwegman, CEO, AB Biotechnologies 

PTV-M03-17-IN-012
Clinical Trials

Advancing Clinical Trial Efficiency with Electronic Informed Consent

APR-M03-17-NI-001
Supply Chain

Direct to Patient Logistics and Technology

Paddy Hanlon, Vice President, Commercial Operations East Coast & Canada, Marken

PTV-M01-17-NS-003
Clinical Trials

Verona Turns to QuintilesIMS for Drug Development

PAO-M03-17-NI-004
Clinical Trials

FDA Approves Bavencio for Rare Skin Cancer

PAO-M03-17-NI-002
Discovery

Big Data: A Big Challenge

PAP-Q1-17-NO-001
Outsourcing

Spending on Contract Research Services Slowing Down

PAP-Q1-17-FA-003
Supply Chain

Keeping the Chain Going

PAP-Q1-17-FA-007
CDMO

Q: What Challenges are Associated with Implementing Cloud Computing within CROs/CDMOs?

PAP-Q1-17-RT-004
Clinical Trials

Q: What Impact Do You Think the Move to Cloud Computing Will Have on the Ability of Contract Service Organizations to Better Meet the Needs of Their Customers?

PAP-Q1-17-RT-003
Supply Chain

Dissolving Boundaries in Worldwide Clinical Trial Logistics for Biological Samples and New Therapies

PAP-Q1-17-CL-011
Biologics

Investing for Successful Advancement of Viral Vector Manufacturing

PAP-Q1-17-CL-007
Clinical Trials

AAPS Expedited Pathways

PAO-M11-16-NI-002
Outsourcing

Expanding Trial Data Demands New Analytical Methods

MCP-M09-16-NI-001
Biologics

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
API

Two Promising Small-Molecule Orphan Drugs in Clinical Trials

PAP-Q04-16-TT-001
Supply Chain

Perspectives on Product Pricing Strategy and Practice

PAP-Q04-16-NC-001
Clinical Trials

Speed-to-Market: Process and Capacity on Demand

PAP-Q04-16-CL-014
API

Meeting Unmet Patient Needs with Small-Volume APIs

PAP-Q04-16-CL-003
Outsourcing

Shaping the Conversation – Bringing Voice & Value

PAP-Q04-16-ED-001
CDMO

Delivering on Unfulfilled Promises – Building a CDMO

PAP-Q03-16-CL-006
Supply Chain

Strong Growth for CRO Market; Tox Testing Poses Challenges

SCP-M07-16-NI-001
CDMO

Increasing the Chances of Finding the Best Possible CRO/CMO Fit

MCP-M05-16-NI-001
Outsourcing

Ways to Lower Costs of Clinical Trials and How CROs Help

APR-M04-16-NI-001
CDMO

Research Database Recommendations

PAP-Q02-16-NI-001
Clinical Trials

Dose and Form Matter: Future of Care Demands Optimal Drug Delivery

PAP-Q02-16-CL-003
API

Look for More Outsourcing of Research Activities in 2016

APR-M01-16-NI-002
Outsourcing

Another Exciting Year for Clinical Research Outsourcing

PAP-Q1-16-FA-002
API

Strong CMO/CDMO Market Outlook for 2016, but Beware Moderating Factors

PAP-Q1-16-FA-001
Clinical Trials

Digital Automation in Clinical Trials: The Promise and Potential

PAP-Q4-15-CL-006
Outsourcing

Advanced Technologies Cited as Essential for Clinical Trial Challenges

LSL-M09-15-NI-001
API

Suiting a Strategy to Fit Biotech Behaviours

MCP-M07-15-NI-001
Outsourcing

Nice Insight Survey: Focus on Automated Laboratory Systems

POP-M07-15-NI-001
Outsourcing

CRO or CMO: Which Is Best For Your Preformulation Needs?

LSL-M05-15-NI-001
Clinical Trials

Cost Forecasting for Clinical Trial Management

PAP-APR-S01-CL-004
Clinical Trials

How a CMO Can Help With Investigational New Drug Applications

PAP-APR-S01-CL-002
Outsourcing

Biopharmaceutical Outsourcing To CROs In Emerging Markets Surges For 2015

LSL-M03-15-NI-002
Outsourcing

Industry Data: Developing Targeted Marketing Strategies

MCP-M02-15-NI-001
Biologics

Logistics Providers Strive to Fulfill Biopharma Needs – Specialty Companies Offer Advantages, but Get a Bad Rap on Price

LSL-M11-14-NI-002
Outsourcing

The Continued Evolution of the Sponsor-CRO Relationship

LSL-M08-14-NI-001
Outsourcing

An Update on the Buzz Around Oncology

LSL-M07-14-NI-002
Outsourcing

Sponsors Not the Only Party to Benefit from Clinical Trials in Emerging Markets

POP-M06-14-NI-001
Outsourcing

Can CROs Help Reduce the Expense of Clinical Trials?

LSL-M05-14-NI-001
Outsourcing

Outsourcing Clinical Research — Trends by Customer Group

LSL-M03-13-NI-001
Clinical Trials

Will A Focus On Innovation Pay Off For Custom Synthesis Providers?

CIO-M08-12-NI-001
Clinical Trials

What's the Buzz Around Oncology?

LSL-M07-12-NI-001
Clinical Trials

Data Management and Information Technology — Do the Benefits Outweigh the Risks?

LSL-M05-12-NI-001
Outsourcing

Outsourcing Clinical Research: Established vs. Emerging Markets

PPO-M05-12-NI-001
Biologics

Biotherapeutics Outpace Conventional Therapies

BIO-M03-12-NI-001
Clinical Trials

Overcoming Barriers to Forming Successful Relationships with CMOs in Emerging Markets

PQO-M12-11-NI-001
Clinical Trials

Where Do Strategic Business Opportunities Lie For Mid-Tier CROs?

PCO-M10-11-NI-001
Clinical Trials

CROs Grow IT Chops To Gain Competitive Edge

FBO-M11-16-NI-001
Clinical Trials

Benefit From Clinical Trials In Emerging Markets While Limiting Risk Exposure

LSL-M09-11-NI-001
//Fix for text overflow in cards